Nutcracker Therapeutics develops a platform to enable the development and manufacturing of all RNA therapeutics.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/14/2022 | Series C | $167MM | $xx.xx | $993.11MM | Arch Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
15,533,005
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arch Venture Partners
|
||||||
09/23/2020 | Series B | $60MM | $xx.xx | $161.22MM | Arch Venture Partners, Bluebird Ventures, Sutter Hill Ventures | |
Price per Share
$xx.xx
Shares Outstanding
23,285,045
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Arch Venture Partners, Bluebird Ventures, Sutter Hill Ventures
|
||||||
03/11/2019 | Series A | $12.3MM | $xx.xx | $104.46MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,039,610
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
04/30/2018 | Series Seed | $4MM | $xx.xx | $5.33MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
22,857,143
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|